Buy HGH Fragment 176-191 & CJC-1295 DAC Pre-Mixed Blend 2.5mg Online UK

Buy HGH Fragment 176-191 & CJC-1295 DAC 2.5mg UK. The HGH Fragment 176-191 & CJC-1295 DAC Pre-Mixed Blend 2.5mg is designed for laboratories studying growth hormone signalling and metabolic pathways. This research formulation combines two well-known peptides into a single pre-mixed solution to simplify laboratory workflows and maintain consistent dosing during experimental studies.

Firstly, HGH Fragment 176-191 is a modified segment of human growth hormone that researchers frequently study for its role in lipid metabolism and fat-related pathways. Meanwhile, CJC-1295 DAC (Drug Affinity Complex) is engineered to extend the half-life of growth hormone releasing hormone analogues, allowing researchers to observe prolonged hormonal activity in controlled settings.

Together, this peptide blend allows laboratories to investigate the potential interaction between targeted lipolysis pathways and extended growth hormone signalling.

Because the peptides are supplied in a pre-mixed formulation, researchers can avoid manual preparation. As a result, laboratory protocols become easier to manage while maintaining reliable and consistent experimental conditions.

This product is intended strictly for laboratory research purposes only and should only be handled by trained research professionals.

About HGH Fragment 176-191

HGH Fragment 176-191 is a synthetic peptide derived from the C-terminal portion of human growth hormone. Researchers frequently study this fragment because it appears to focus specifically on lipolysis pathways without significantly affecting other growth hormone functions.

Laboratory research involving HGH Fragment 176-191 commonly explores:

• Lipid metabolism pathways

• Fat breakdown mechanisms

• Body composition research

• Metabolic regulation studies

Because of its targeted mechanism, the peptide has become a common subject in metabolic and obesity-related research.

About CJC-1295 DAC

CJC-1295 DAC is a modified analogue of growth hormone releasing hormone (GHRH). The DAC (Drug Affinity Complex) component extends the peptide’s stability and circulation time, allowing researchers to observe longer-lasting growth hormone stimulation during experimental studies.

Scientific investigations involving CJC-1295 DAC often focus on:

• Growth hormone secretion research

• Lean tissue development studies

• Hormonal signalling pathways

• Metabolic and endocrine research

The longer half-life provided by DAC modification makes it particularly useful in studies that require sustained hormonal activity.

Key Features

• 2.5mg peptide blend formulation

• Combines HGH Fragment 176-191 + CJC-1295 DAC

• High purity research compound

• Pre-mixed format for easier laboratory use

• Designed for consistent dosing in research protocols

• Suitable for metabolic and endocrine studies

Storage Guidelines

To maintain stability and integrity of the peptide formulation:

• Store between 2°C and 8°C

• Do not freeze the solution

• Avoid direct sunlight or heat exposure

• Keep cartridges sealed until laboratory use

Proper storage helps maintain the peptide’s quality throughout research applications.